Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The iD2: A Smart Eye Drop Cap Monitor for Eye Drop Adherence

NCT: NCT07664943 · NOT_YET_RECRUITING

NCT IDNCT07664943
StatusNOT_YET_RECRUITING
Start Date2026-09-01
Completion2027-08-31
SponsorUniversal Adherence LLC (INDUSTRY)
First posted
Last updated

Brief Summary

Most patients with glaucoma use eye drops to lower their intraocular pressure. However, poor adherence to prescribed eye drop regimens can lead to significant loss of vision-related quality of life. This study will test the iDrop Device (iD2), a device-on-cap electronic platform monitor designed to accurately track when a research participant removes an eye drop bottle cap, wirelessly communicate usage data to a database accessible to researchers, and send on-demand alerts when a medication is due. A device capable of tracking eye drop usage and sending dosage alerts will test the hypothesis that electronic reminders improve medication adherence and help research subjects improve their eye drop taking behavior. While our primary focus is on glaucoma adherence, this device could also benefit those with other chronic eye conditions requiring regular eye drop treatment, such as dry eye, corneal endothelial disease, eye infections, and uveitis.

Frequently Asked Questions

What is The iD2: A Smart Eye Drop Cap Monitor for Eye Drop Adherence?

The iD2: A Smart Eye Drop Cap Monitor for Eye Drop Adherence is a clinical trial registered under NCT07664943. Current status: NOT_YET_RECRUITING.

What is the status of NCT07664943?

The current status of NCT07664943 (The iD2: A Smart Eye Drop Cap Monitor for Eye Drop Adherence) is: NOT_YET_RECRUITING.

When did The iD2: A Smart Eye Drop Cap Monitor for Eye Drop Adherence start?

The iD2: A Smart Eye Drop Cap Monitor for Eye Drop Adherence started on 2026-09-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.